Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Which factors raise HCC risk in patients with cured HCV?
Predictors of hepatocellular carcinoma (HCC) differ in patients with virologically cured hepatitis C virus (HCV) infection with and without cirrhosis, according to a study. However, changes in fibrosis-4 (FIB-4) scores over time are associated with HCC risk in both cohorts.
Which factors raise HCC risk in patients with cured HCV?
24 Nov 2022
Some COVID-19 patients see persistent lung disease 6 months after infection
Radiographic and physiologic signs of lung disease persist for up to 6 months after infection from COVID-19, reports a recent study.
Some COVID-19 patients see persistent lung disease 6 months after infection
24 Nov 2022
ANCA-positive infective endocarditis tied to longer disease duration, kidney injury
A significant number of patients with infective endocarditis have been found to have antineutrophil cytoplasmic antibody (ANCA), which is associated with longer disease duration, more frequent purpura, and kidney involvement, results of a study has shown.
ANCA-positive infective endocarditis tied to longer disease duration, kidney injury
22 Nov 2022
Entecavir plus traditional Chinese medicine cuts HCC risk in CHB
Among patients with chronic hepatitis B (CHB), treatment with entecavir (ETV) and Biejia-Ruangan compound (BRC), an antifibrotic traditional Chinese medicine, helps reduce the risk of hepatocellular carcinoma (HCC), a recent study reports.
Entecavir plus traditional Chinese medicine cuts HCC risk in CHB
22 Nov 2022
TB rates elevated after ART initiation in PLHIV
People living with HIV (PLHIV) who initiate antiretroviral therapy (ART) are at an increased risk of developing tuberculosis (TB), particularly in the first 3 months after starting ART, according to a study presented at HIV Glasgow 2022.
TB rates elevated after ART initiation in PLHIV
21 Nov 2022
COVID-19 may trigger hair, nail disorders
Hair and nail disorders may occur following contraction of COVID-19 infection, with the development of the dermatological conditions related to a history of severe infection, a study has found.
COVID-19 may trigger hair, nail disorders
21 Nov 2022
High-flow oxygen does not reduce mortality in COVID-19 respiratory failure
The use of high-flow nasal cannula oxygen, as opposed to standard oxygen, in the first-line setting, did not reduce mortality rates in patients admitted to intensive care units (ICUs) for respiratory failure due to COVID-19, results of the SOHO-COVID trial showed.
High-flow oxygen does not reduce mortality in COVID-19 respiratory failure
20 Nov 2022
H. pylori eradication eases metabolic dysfunction, steatosis in NAFLD
Among patients with nonalcoholic fatty liver disease (NAFLD), eradication treatment against Helicobacter pylori may help improve liver steatosis and metabolic parameters, a recent study has found.
H. pylori eradication eases metabolic dysfunction, steatosis in NAFLD
20 Nov 2022
Low use of CVD prevention strategies in people with HIV
There is an underutilization of cardiovascular disease (CVD) prevention strategies in people living with HIV (PLHIV) who are at risk of CVD, according to a study presented at HIV Glasgow 2022.
